Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy.
Saved in:
| Title: | Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy. |
|---|---|
| Authors: | Hermawan, Adam1 (AUTHOR) adam_apt@ugm.ac.id, Putri, Herwandhani2 (AUTHOR) |
| Source: | BMC Genomic Data. 9/16/2022, Vol. 23 Issue 1, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
